The startup, Mindstrong Health Inc., succeeded in raising more than $14M in the first round of capital raising. This company specializes in developing efficient and accurate digital biomarkers used in diagnosing various neuropsychiatric treatments. The company has pioneered technology which helps physicians monitor the brain’s functioning using smartphones.
Win for Mental Health
Speaking to the press, the company’s co-founder and President, Dr. Tom Insel expressed his excitement about the significant progress made possible by their innovations. The physician described the news as a positive step in the right direction as far as battling mental disorders is concerned.
Four venture capitalist companies came together to raise the $14 million in seed money for Mindstrong Health. They are:-
- ARCH Venture Partners
- Optum Ventures
- The One Mind Brain Health Impact Fund
- Foresite Capital Inc.
Meet the Staff
The firm has hired an experienced panel of experts to run the day to day affairs of the establishment. These young professionals bring an untold wealth of knowledge and skills to the table. The CEO of Foresite Capital, Jim Tananbaum hinted at the results of their clinical trials coming out very soon. Those results would irrevocably demonstrate the effectiveness of using the gadgets and gizmos developed by Mindstrong Health Inc.
Accurate Diagnosis Saves Lives
Mindstrong’s CEO, Dr. Paul Dagum, echoed the same sentiments adding how the tech company was devoted to revolutionizing the neuropsychiatric disorders realm with powerful and accurate diagnostic tools and measures. Follow Foresite Capital on Twitter.
Introducing Jim Tananbaum
Mr. Jim Tananbaum is a serial investor and technopreneur of epic proportions. Jim Tananbaum holds a spot on 2017’s Forbes List of the top 100 most influential investors. Since 2010, Jim has been associated with several high-profile tech startups focused on the medical sector. Jim’s 25-year experience has witnessed him serving as a leader in companies like Prospect Venture Partners, Jazz Pharmaceuticals, Healtheon, Amira Pharmaceuticals and the Amerigroup.
Jim studied Medicine at the prestigious Harvard Medical School in the late eighties. Later, Jim enrolled at Yale University to pursue twin degrees in B.S.E.E and, in Bachelor of Science. He topped his medical studies with a top honor MBA certification from Harvard’s Business College.